Back to Allspring Global Investments Holdings, LLC Allspring Global Investments Holdings, LLC

JANXJANX

Showing 9 of 16 quarters

Position history for Allspring Global Investments Holdings, LLCAllspring Global Investments Holdings, LLC's holdings in Janux Therapeutics, Inc.

Yes. Allspring Global Investments Holdings holds 209,002 shares of JANX (Janux Therapeutics), worth $3.5M, as of its Q3 2026 13F filing. It increased the position by 42,910 shares (+25.8%) from Q2 2026. Allspring Global Investments Holdings has held JANX since Q1 2026, across 3 quarterly 13F filings.

Current Value

$3.5M

Current Shares

209,002

Total Value Change

+$3.3M

Total Shares Change

+203,151

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
209,002
+25.8%
$3.5M0.0%$17.28
33
2026-Q2
Decreased
166,092
-1.7%
$2.4M0.0%$15.36
0
2026-Q1
New
168,976
—
$2.5M0.0%$13.90
36
2025-Q4
Exited
0
-100.0%
$00.0%$13.80
0
2025-Q3
New
8,454
—
$206,6160.0%$24.44
32
2025-Q2
Exited
0
-100.0%
$00.0%$23.10
0
2025-Q1
Increased
9,033
+54.0%
$243,8910.0%$27.00
32
2024-Q4
Increased
5,865
+0.2%
$314,0120.0%$53.54
23
2024-Q3
Decreased
5,851
-6.9%
$265,8100.0%$46.25
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used